The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Microalbumin Random Urine with Creatinine
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
Also known as: Cholesterol, HDL,Fasting Lipids,Cholesterol, LDL, Fasting Lipids, Lipid Panel (fasting), Lipid Profile (fasting), Lipids
The DH-2. Diabetes Health panel contains 5 tests with 64 biomarkers.
Brief Description: The DH-2 Diabetes Health panel is an expanded diagnostic tool designed for comprehensive diabetes management and assessment of related health risks. It includes a range of tests: CBC with Differential and Platelets, Comprehensive Metabolic Panel (CMP), Hemoglobin A1c, Lipid Panel, and Random Urine Microalbumin with Creatinine. This panel provides a detailed view of a patient's blood sugar control, kidney function, liver function, lipid levels, and overall health status, making it a valuable resource in managing diabetes and its complications.
Collection Method: Blood Draw and Urine Collection
Specimen Type: Whole Blood, Serum, and Urine
Test Preparation: Patient should be fasting for at least 9 hours prior to collection.
The DH-2 Diabetes Health panel is typically ordered for individuals with a diabetes diagnosis to monitor the disease's progression and manage its complications. It's also used for patients with prediabetes or those at high risk due to factors like obesity, hypertension, or a family history of diabetes. The panel helps in adjusting treatment plans, lifestyle changes, and monitoring the effectiveness of interventions to reduce the risk of diabetes-related complications.
CBC with Differential and Platelets: Offers a comprehensive look at the various cells in the blood, helping to identify infections, anemia, and other blood disorders that could complicate diabetes management.
Comprehensive Metabolic Panel (CMP): Assesses glucose levels, electrolyte and fluid balance, kidney function, and liver function, providing a snapshot of the patient's metabolic health and how diabetes might be impacting these areas.
Hemoglobin A1c: Measures average blood glucose levels over the past two to three months, giving a picture of long-term glucose control.
Lipid Panel: Evaluates the levels of cholesterol and triglycerides in the blood, important for assessing cardiovascular risk in diabetic patients.
Random Urine Microalbumin with Creatinine: Detects early signs of kidney damage by measuring the small amounts of albumin in the urine, a common complication of diabetes.
The DH-2 Diabetes Health panel offers a comprehensive overview of diabetes management, but further detailed assessments can be achieved with the DH-3 and DH-4 panels for those needing a deeper dive into their health status.
DH-3 Diabetes Health Panel: This panel adds C-Reactive Protein (CRP) to assess inflammation and cardiovascular risk, which is crucial for diabetes patients who have an elevated risk for heart disease. Additionally, it includes Insulin levels to evaluate the body's insulin production and its efficiency, enhancing the diabetes management strategy.
DH-4 Diabetes Health Panel: The most extensive panel, DH-4, includes all tests from DH-3 and further incorporates a 2 Specimen Glucose Tolerance Test and a 2 Specimen Insulin Response to Glucose. These tests provide an in-depth analysis of glucose metabolism and insulin sensitivity, crucial for diagnosing different types of diabetes and for fine-tuning treatment plans.
The DH-2 panel is designed to monitor diabetes and its control but also checks for conditions such as liver dysfunction, infections or anemia (via CBC), dyslipidemia (through the Lipid Panel), and early kidney damage (via urine microalbumin). This comprehensive approach aids in preventing and managing diabetes complications.
Healthcare professionals use the DH-2 panel results to tailor diabetes management plans, adjust medications, and recommend lifestyle changes. High A1c levels might necessitate changes in medication, elevated lipid levels could lead to dietary changes or statin therapy, and signs of kidney damage might prompt adjustments in diabetes care to protect renal function.
The DH-2 Diabetes Health panel stands as a robust tool in the effective management of diabetes, offering a broad perspective on a patient's health and the impact of diabetes. By providing insights into various health aspects affected by diabetes, this panel enables healthcare professionals to devise comprehensive and personalized management plans, ensuring better health outcomes and quality of life for those living with diabetes.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.